Therapy - 2
Patients
>50 years of age:
Bone
marrow transplants not an option
75%
survival after 5 years
Current therapy (cont’d):
Immunomodulation
therapy:
Anti-thymocyte globulins
Anti-lymphocyte globulins
Cyclosporin
cyclophosphamide